Sommer Doron D, Rotenberg Brian W, Sowerby Leigh J, Lee John M, Janjua Arif, Witterick Ian J, Monteiro Eric, Gupta Michael K, Au Michael, Nayan Smriti
Division of Otolaryngology-Head and Neck Surgery, Department of Surgery McMaster University, Hamilton, Canada.
Department of Otolaryngology-Head and Neck Surgery, Western University, London, Canada.
Int Forum Allergy Rhinol. 2016 Apr;6(4):385-91. doi: 10.1002/alr.21678. Epub 2016 Jan 11.
Aspirin-exacerbated respiratory disease (AERD) is a clinical triad consisting of aspirin/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and nasal polyposis. Although respiratory reactions following ingestion of ASA and other nonsteroidal anti-inflammatory drugs (NSAIDs) are considered a hallmark of the condition, respiratory inflammation persists despite patients' avoidance of NSAIDs. Treatment of this condition remains challenging and includes both medical and surgical options.
A prospective crossover single-blind multicenter study involving 4 tertiary rhinology care centers (n = 30) was conducted in which patients were randomized to start with either 6 weeks of a regular diet or 6 weeks of a low-salicylate diet and then crossed-over for a total study duration of 12 weeks. Patients were evaluated at baseline, 6 weeks (at crossover) and 12 weeks using subjective measures (22-item Sino-Nasal Outcome Test-22 [SNOT-22], Nasal Sinus Symptom Scale [NSSS], and 7-item Asthma Control Questionnaire [ACQ-7]) and objective outcome instruments (Perioperative Sinus Evaluation [POSE] and Lund-Kennedy Endoscopic Score [LKES]).
Data was analyzed for 30 patients. Wilcoxon rank sum tests determined that patients had improvement in their median difference in scores, which were all statistically significant, when they followed the low-salicylate diet compared to their regular diet: SNOT-22: 15 (95% confidence interval [CI], 10 to 23.25), p < 0.001; NSSS: 3 (95% CI, 1.75 to 4), p < 0.001; ACQ-7: 4.5 (95% CI, 1.5 to 8.5), p < 0.001; POSE 6 (95% CI, 2.5 to 10), p < 0.001; and LKES: 2.5 (95% CI, 1.5 to 4), p < 0.001).
The low-salicylate diet may offer a novel treatment adjunct to the current management of AERD. Clinically and statistically significant improvements on both subjective and objective outcome measures were noted for the upper and lower respiratory tracts.
阿司匹林加重性呼吸疾病(AERD)是一种临床三联征,由阿司匹林/乙酰水杨酸(ASA)敏感性、支气管哮喘和鼻息肉病组成。尽管摄入ASA和其他非甾体抗炎药(NSAIDs)后的呼吸道反应被认为是该病症的一个标志,但即便患者避免使用NSAIDs,呼吸道炎症仍会持续存在。这种病症的治疗仍然具有挑战性,包括药物和手术治疗方案。
开展了一项前瞻性交叉单盲多中心研究,涉及4个三级鼻科学护理中心(n = 30),患者被随机分为两组,一组先进行6周的常规饮食,另一组先进行6周的低水杨酸盐饮食,然后交叉,总研究时长为12周。在基线、6周(交叉时)和12周时,使用主观测量方法(22项鼻鼻窦结局测试-22[SNOT-22]、鼻窦症状量表[NSSS]和7项哮喘控制问卷[ACQ-7])和客观结局指标(围手术期鼻窦评估[POSE]和伦德-肯尼迪内镜评分[LKES])对患者进行评估。
对30例患者的数据进行了分析。威尔科克森秩和检验确定,与常规饮食相比,患者遵循低水杨酸盐饮食时,其得分的中位数差异有改善,且均具有统计学意义:SNOT-22:15(95%置信区间[CI],10至23.25),p < 0.001;NSSS:3(95%CI,1.75至4),p < 0.001;ACQ-7:4.5(95%CI,1.5至8.5),p < 0.001;POSE 6(95%CI,2.5至10),p < 0.001;LKES:2.5(95%CI,1.5至4),p < 0.001。
低水杨酸盐饮食可能为目前AERD的治疗提供一种新的辅助治疗方法。在上呼吸道和下呼吸道的主观和客观结局测量方面均观察到了具有临床和统计学意义的改善。